Stay updated on HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Immune Thrombocytopenia (ITP), while retaining some key identifiers like the study code and revision number.SummaryDifference29%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedHutchison Medipharma Limited has been added with a new revision v2.14.2, replacing the previous version v2.14.1 of Hutchison MediPharma.SummaryDifference0.3%
Stay in the know with updates to HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.